Collagen Scaffold for Implantable Glucose Sensors
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Chronically implantable medical devices, such as biosensors, often provoke inflammation and fibrosis due to tissue trauma and foreign body responses, leading to progressive loss of sensor function and inadequate long-term glucose monitoring in diabetic patients.
Innovation Solution
A biocompatible collagen scaffold with a three-dimensional porous structure, cross-linked using glutaraldehyde or nordihydroguaiaretic acid, is applied to medical devices to enhance biocompatibility and reduce tissue reactions, while stimulating angiogenesis and inhibiting biofouling.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If chronically implantable medical devices are used, then medical monitoring function is provided, but inflammation and fibrosis occur due to tissue trauma and foreign body response
Solution Approach 1:
A collagen scaffold is introduced as an intermediary layer between the implantable medical device and the surrounding tissue. This scaffold acts as a biocompatible mediator that reduces direct tissue trauma and foreign body response, thereby decreasing inflammation and fibrosis while maintaining sensor functionality over chronic implantation periods.
Solution Approach 2:
The collagen scaffold modifies the physical and chemical parameters at the device-tissue interface by providing a natural, biodegradable matrix that changes its properties over time as it degrades. This parameter change from a structured scaffold to degraded components reduces chronic inflammation while maintaining initial biocompatibility.
2Productivity
If implantable biosensors are used for continuous glucose monitoring, then diabetes management is improved, but sensor function is lost due to biofouling and foreign body response
Solution Approach 1:
The collagen scaffold is applied to the sensor surface before implantation to pre-establish a biocompatible interface. This preliminary action prevents immediate biofouling and reduces the foreign body response from the outset, allowing the sensor to maintain functionality throughout the continuous monitoring period.
Solution Approach 2:
The collagen scaffold provides a porous structure that allows selective mass transport while preventing protein adsorption and cell adhesion that cause biofouling. The porous architecture maintains sensor accessibility to analytes while protecting against fouling agents, ensuring reliable continuous monitoring.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The collagen scaffold improves the longevity and biocompatibility of implanted devices by reducing inflammation and fibrosis, maintaining sensor functionality and sensitivity over extended periods.
Implementation Method 1
cross-linked using glutaraldehyde or nordihydroguaiaretic acid
Implementation Method 2
three-dimensional porous structure
Data Source
AI summary
The subject invention concerns non-degradable three dimensional porous collagen scaffolds and coatings. These scaffolds can be prepared around sensors for implantation into a body. A specific embodiment of the invention concerns implantable glucose sensors. Sensors comprising a collagen scaffold of the invention have improved biocompatibility by minimizing tissue reactions while stimulating angiogenesis. The subject invention also concerns methods for preparing collagen scaffolds of the invention. The subject invention also concerns sensors that have a collagen scaffold of the invention around the exterior of the sensor.